The blood–tumour barrier in cancer biology and therapy
The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
Soria, J.-C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713137 · Cited by 5,508
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
Ramalingam, S. S., Vansteenkiste, J., Planchard, D., Cho, B. C., Gray, J. E., Ohe, Y., Zhou, C., Reungwetwattana, T., Cheng, Y., Chewaskulyong, B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1913662 · Cited by 2,914
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz150 · Cited by 2,585
Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer
Peters, S., Camidge, D. R., Shaw, A. T., Gadgeel, S., Ahn, J. S., Kim, D.-W., Ou, S.-H. I., Pérol, M., Dziadziuszko, R., Rosell, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704795 · Cited by 2,527
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
Wu, Y.-L., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., Goldman, J. W., Laktionov, K., Kim, S.-W., Kato, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027071 · Cited by 1,798
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914609 · Cited by 1,326
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, H. A., Forsyth, P. A., Algazi, A., Hamid, O., Hodi, F. S., Moschos, S. J., Khushalani, N. I., Lewis, K., Lao, C. D., Postow, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805453 · Cited by 1,321
Real-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138
Weller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. L., Balana, C., Chinot, O., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30194-8 · Cited by 1,088
Brastianos, P. K., Carter, S. L., Santagata, S., Cahill, D. P., Taylor-Weiner, A., Jones, R. T., Van Allen, E. M., Lawrence, M. S., Horowitz, P. M., Cibulskis, K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0369 · Cited by 1,082
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
Wnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
Dijkers, E. C., Oude Munnink, T. H., Kosterink, J. G., Brouwers, A. H., Jager, P. L., de Jong, J. R., van Dongen, G. A., Schröder, C. P., Lub-de Hooge, M. N., & de Vries, E. G. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.12 · Cited by 805
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002230 · Cited by 794
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Carpentier, A., Canney, M., Vignot, A., Reina, V., Beccaria, K., Horodyckid, C., Karachi, C., Leclercq, D., Lafon, C., Chapelon, J.-Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6086 · Cited by 757
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
Ballard, P., Yates, J. W. T., Yang, Z., Kim, D.-W., Yang, J. C.-H., Cantarini, M., Pickup, K., Jordan, A., Hickey, M., Grist, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0399 · Cited by 718
Gadgeel, S. M., Gandhi, L., Riely, G. J., Chiappori, A. A., West, H. L., Azada, M. C., Morcos, P. N., Lee, R.-M., Garcia, L., Yu, L., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70362-6 · Cited by 698
Lockman, P. R., Mittapalli, R. K., Taskar, K. S., Rudraraju, V., Gril, B., Bohn, K. A., Adkins, C. E., Roberts, A., Thorsheim, H. R., Gaasch, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1564 · Cited by 693
Self-citationCarare, R. O., Bernardes‐Silva, M., Newman, T. A., Page, A. M., Nicoll, J. A. R., Perry, V. H., & Weller, R. O. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00926.x · Cited by 665
The dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616
Costa, D. B., Shaw, A. T., Ou, S.-H. I., Solomon, B. J., Riely, G. J., Ahn, M.-J., Zhou, C., Shreeve, S. M., Selaru, P., Polli, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.0539 · Cited by 599
Lin, N. U., Borges, V., Anders, C., Murthy, R. K., Paplomata, E., Hamilton, E., Hurvitz, S., Loi, S., Okines, A., Abramson, V., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00775 · Cited by 544
Glioblastoma: defining tumor niches
Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.009 · Cited by 522
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508
Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer
Mok, T. S. K., Wu, Y.-L. L. C., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S., Shepherd, F. A., He, Y.-M., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · QUT ePrints (Queensland University of Technology) · Cited by 463
Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454
Boire, A., Brastianos, P. K., Garzia, L., & Valiente, M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0220-y · Cited by 446
Vieira, D., & Gamarra, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117210 · Cited by 427
Macrophages at CNS interfaces: Ontogeny and function in health and disease
Kierdorf, K., Masuda, T., Jordão, M. J. C., & Prinz, M. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0201-x · Cited by 416
Doolittle, N. D., Miner, M. E., Hall, W. A., Siegal, T., Hanson, E. J., Osztie, E., McAllister, L. D., Bubalo, J. S., Kraemer, D. F., Fortin, D., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y · Cited by 399
Incidence of gliomas by anatomic location
Larjavaara, S., Mäntylä, R., Salminen, T., Haapasalo, H., Raitanen, J., Jääskeläinen, J., & Auvinen, A. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-016 · Cited by 396
Brufsky, A. M., Mayer, M., Rugo, H. S., Kaufman, P. A., Tan-Chiu, E., Tripathy, D., Tudor, I. C., Wang, L. I., Brammer, M. G., Shing, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2962 · Cited by 386
Miroshnikova, Y. A., Mouw, J. K., Barnes, J. M., Pickup, M. W., Lakins, J. N., Kim, Y., Lobo, K., Persson, A. I., Reis, G. F., McKnight, T. R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3429 · Cited by 383
Targeting the transferrin receptor for brain drug delivery
Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 370
Régina, A., Demeule, M., Ché, C., Lavallée, I., Poirier, J., Gabathuler, R., Béliveau, R., & Castaigne, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.260 · Cited by 368
Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity
Yao, Y., Chen, Z.-L., Norris, E. H., & Strickland, S. (2014) · Nature Communications · doi:10.1038/ncomms4413 · Cited by 357
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Phoenix, T. N., Patmore, D. M., Boop, S., Boulos, N., Jacus, M. O., Patel, Y. T., Roussel, M. F., Finkelstein, D., Goumnerova, L., Perreault, S., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.002 · Cited by 353
Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.
Sørensen, J. B., Hansen, H. H., Hansen, M., & Dombernowsky, P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1474 · Cited by 339
The Vascular Basement Membrane as “Soil” in Brain Metastasis
Carbonell, W. S., Ansorge, O., Sibson, N., & Muschel, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005857 · Cited by 329
Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 311
The Evolving Landscape of Brain Metastasis
Valiente, M., Ahluwalia, M. S., Boire, A., Brastianos, P. K., Goldberg, S. B., Lee, E. Q., Le Rhun, E., Preusser, M., Winkler, F., & Soffietti, R. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.01.003 · Cited by 309
Bronger, H., König, J., Kopplow, K., Steiner, H.-H., Ahmadi, R., Herold-Mende, C., Keppler, D., & Nies, A. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1271 · Cited by 295
Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier
Carman, A. J., Mills, J. H., Krenz, A., Kim, D.-G., & Bynoe, M. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3337-11.2011 · Cited by 276
Portnow, J., Badie, B., Chen, M., Liu, A., Blanchard, S., & Synold, T. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1349 · Cited by 255
Kumthekar, P., Tang, S.-C., Brenner, A. J., Kesari, S., Piccioni, D. E., Anders, C., Carrillo, J., Chalasani, P., Kabos, P., Puhalla, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3258 · Cited by 250
Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases
Kodama, T., Hasegawa, M., Takanashi, K., Sakurai, Y., Kondoh, O., & Sakamoto, H. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2578-6 · Cited by 243
Arvanitis, C. D., Askoxylakis, V., Guo, Y., Datta, M., Kloepper, J., Ferraro, G. B., Bernabeu, M. O., Fukumura, D., McDannold, N., & Jain, R. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807105115 · Cited by 236
Zhou, W., Chen, C., Shi, Y., Wu, Q., Gimple, R. C., Fang, X., Huang, Z., Zhai, K., Ke, S. Q., Ping, Y.-F., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.002 · Cited by 231
Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0909 · Cited by 227
Thomas, F. C., Taskar, K., Rudraraju, V., Goda, S., Thorsheim, H. R., Gaasch, J. A., Mittapalli, R. K., Palmieri, D., Steeg, P. S., Lockman, P. R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9964-5 · Cited by 226
Self-citationFitzgerald, D. P., Palmieri, D., Hua, E., Hargrave, E., Herring, J. M., Qian, Y., Vega-Valle, E., Weil, R. J., Stark, A. M., Vortmeyer, A. O., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9193-z · Cited by 218
Self-citationIntracellular transport and regulation of transcytosis across the blood–brain barrier
Villaseñor, R., Lampe, J., Schwaninger, M., & Collin, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2982-x · Cited by 209
Astrocytes, the rising stars of the glioblastoma microenvironment
Brandao, M., Simon, T., Critchley, G., & Giamas, G. (2019) · Glia · doi:10.1002/glia.23520 · Cited by 208
Prados, M. D., Schold, S. C., Fine, H. A., Jaeckle, K., Hochberg, F., Mechtler, L., Fetell, M. R., Phuphanich, S., Feun, L., Janus, T. J., et al. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.96 · Cited by 202
Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
Taskar, K. S., Rudraraju, V., Mittapalli, R. K., Samala, R., Thorsheim, H. R., Lockman, J., Gril, B., Hua, E., Palmieri, D., Polli, J. W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-011-0601-8 · Cited by 202
Self-citationImmune Surveillance of the CNS following Infection and Injury
Russo, M. V., & McGavern, D. B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.002 · Cited by 191
Park, S., Lee, M.-H., Seong, M., Kim, S. T., Kang, J.-H., Cho, B. C., Lee, K. H., Cho, E. K., Sun, J.-M., Lee, S.-H., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.017 · Cited by 186
Kotb, S., Detappe, A., Lux, F., Appaix, F., Barbier, E. L., Tran, V.-L., Plissonneau, M., Gehan, H., Lefranc, F., Rodriguez-Lafrasse, C., et al. (2016) · Theranostics · doi:10.7150/thno.14018 · Cited by 182
Lyle, L. T., Lockman, P. R., Adkins, C. E., Mohammad, A. S., Sechrest, E., Hua, E., Palmieri, D., Liewehr, D. J., Steinberg, S. M., Kloc, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1836 · Cited by 175
Self-citationMorikawa, A., Peereboom, D. M., Thorsheim, H. R., Samala, R., Balyan, R., Murphy, C. G., Lockman, P. R., Simmons, A., Weil, R. J., Tabar, V., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou141 · Cited by 173
Self-citationPrognostic Factors for Long-Term Survival after Glioblastoma
Walid, M. S. (2008) · The Permanente Journal · doi:10.7812/tpp/08-027 · Cited by 171
Murthy, R., Borges, V. F., Conlin, A., Chaves, J., Chamberlain, M., Gray, T., Vo, A., & Hamilton, E. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30256-0 · Cited by 170
Regulation of ABC Transporters Blood–Brain Barrier
Miller, D. S. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.002 · Cited by 163
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Hong, S.-S., Oh, K. T., Choi, H.-G., & Lim, S.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100540 · Cited by 162
Ruan, S., Qin, L., Xiao, W., Hu, C., Zhou, Y., Wang, R., Sun, X., Yu, W., He, Q., & Gao, H. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802227 · Cited by 154
Tiwary, S., Morales, J. E., Kwiatkowski, S. C., Lang, F. F., Rao, G., & McCarty, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26636-6 · Cited by 149
Verry, C., Dufort, S., Lemasson, B., Grand, S., Pietras, J., Troprès, I., Crémillieux, Y., Lux, F., Mériaux, S., Larrat, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay5279 · Cited by 145
Altered blood–brain barrier integrity in adult aquaporin-4 knockout mice
Zhou, J., Kong, H., Hua, X., Xiao, M., Ding, J., & Hu, G. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3282f2b4eb · Cited by 144
Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases
Gril, B., Paranjape, A. N., Woditschka, S., Hua, E., Dolan, E. L., Hanson, J., Wu, X., Kloc, W., Iżycka‐Świeszewska, E., Duchnowska, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05030-w · Cited by 141
Self-citationHarter, P. N., Bernatz, S., Scholz, A., Zeiner, P. S., Zinke, J., Kiyose, M., Blasel, S., Beschorner, R., Senft, C., Bender, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5696 · Cited by 133
Nduom, E. K.-E., Yang, C., Merrill, M. J., Zhuang, Z., & Lonser, R. R. (2013) · Journal of neurosurgery · doi:10.3171/2013.3.jns122226 · Cited by 132
Reactive Astrocytes in Brain Metastasis
Wasilewski, D., Priego, N., Torre, C. F., & Valiente, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00298 · Cited by 131
Soe, Z. C., Kwon, J. B., Thapa, R. K., Ou, W., Nguyen, H. T., Gautam, M., Oh, K. T., Choi, H., Ku, S., Yong, C. S., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020063 · Cited by 130
Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines
Valiente, M., Swearingen, A. E. D. V., Anders, C. K., Bairoch, A., Boire, A. A., Bos, P. D., Cittelly, D. M., Erez, N., Ferraro, G. B., Fukumura, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0291 · Cited by 129
Self-citationAvraham, H. K., Jiang, S., Fu, Y., Nakshatri, H., Ovadia, H., & Avraham, S. (2014) · The Journal of Pathology · doi:10.1002/path.4304 · Cited by 128
Liu, H.-L., Huang, C.-Y., Chen, J.-Y., Wang, H.-Y. J., Chen, P.-Y., & Wei, K.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114311 · Cited by 124
Duchnowska, R., Pęksa, R., Radecka, B. S., Mandat, T. S., Trojanowski, T., Jarosz, B., Czartoryska-Arłukowicz, B., Olszewski, W. P., Och, W., Kalinka‐Warzocha, E., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0702-8 · Cited by 124
Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases
Osswald, M., Blaes, J., Liao, Y., Solecki, G., Gömmel, M., Berghoff, A. S., Salphati, L., Wallin, J. J., Phillips, H. S., Wick, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1327 · Cited by 122
Immunotherapy in CNS cancers: the role of immune cell trafficking
Ratnam, N. M., Gilbert, M. R., & Giles, A. J. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy084 · Cited by 120
Kroll, R. A., Pagel, M. A., Muldoon, L. L., Muldoon, L. L., Roman-Goldstein, S., Fiamengo, S. A., Neuwelt, E. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199810000-00090 · Cited by 118
Regina, A., Demeule, M., Tripathy, S., Lord-Dufour, S., Currie, J.-C., Iddir, M., Annabi, B., Castaigne, J.-P., & Lachowicz, J. E. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0399 · Cited by 112
Rodriguez, P. L., Jiang, S., Fu, Y., Avraham, S., & Avraham, H. K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28433 · Cited by 111
Hurvitz, S. A., O’Shaughnessy, J., Mason, G., Yardley, D. A., Jahanzeb, M., Brufsky, A., Rugo, H. S., Swain, S. M., Kaufman, P. A., Tripathy, D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2366 · Cited by 109
Premetastatic soil and prevention of breast cancer brain metastasis
Liu, Y., Kosaka, A., Ikeura, M., Kohanbash, G., Fellows-Mayle, W. K., Snyder, L. A., & Okada, H. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not031 · Cited by 107
Mittapalli, R. K., Liu, X., Adkins, C. E., Nounou, M. I., Bohn, K. A., Terrell, T. B., Qhattal, H. S., Geldenhuys, W. J., Palmieri, D., Steeg, P. S., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0132 · Cited by 101
Self-citationA Blazing Landscape: Neuroinflammation Shapes Brain Metastasis
Doron, H., Pukrop, T., & Erez, N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1805 · Cited by 100
Pokorny, J. L., Calligaris, D., Gupta, S. K., Iyekegbe, D. O., Mueller, D. J., Bakken, K. K., Carlson, B. L., Schroeder, M. A., Evans, D. L., Lou, Z., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2588 · Cited by 99
Valdor, R., García‐Bernal, D., Bueno, C., Rodenas, M., Moraleda, J. M., Macián, F., & Martínez, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19804 · Cited by 97
Bao, X., Wu, J., Xie, Y., Kim, S., Michelhaugh, S., Jiang, J., Mittal, S., Sanai, N., & Li, J. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1710 · Cited by 92
Amaral, T. M. S., Kiecker, F., Schaefer, S., Stege, H. M., Kaehler, K. C., Terheyden, P. A. M., Gesierich, A., Gutzmer, R., Haferkamp, S., Uttikal, J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000333 · Cited by 91
Selective Permeabilization of the Blood–Brain Barrier at Sites of Metastasis
Connell, J. J., Chatain, G. P., Cornelissen, B. T., Vallis, K. A., Hamilton, A., Seymour, L. W., Anthony, D. C., & Sibson, N. R. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt276 · Cited by 90
Li, Y., Zheng, X., Gong, M., & Zhang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12708 · Cited by 90
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
Askoxylakis, V., Ferraro, G. B., Kodack, D. P., Badeaux, M. D., Shankaraiah, R. C., Seano, G., Kloepper, J., Vardam, T. D., Martin, J. D., Naxerova, K., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv313 · Cited by 87
Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer
Terrell-Hall, T. B., Nounou, M. I., ElAmrawy, F., Griffith, J. I. G., & Lockman, P. R. (2017) · Oncotarget · doi:10.18632/oncotarget.19634 · Cited by 84
Jackson, S., WEINGART, J. D., Nduom, E. K.-E., Harfi, T. T., George, R. T., McAreavey, D., Ye, X., Anders, N. M., Peer, C. J., Figg, W. D., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0088-8 · Cited by 77
Wu, C., Sundararajan, V., Sheu, B., Huang, R. Y., & Wei, L. (2019) · Cancers · doi:10.3390/cancers12010024 · Cited by 76
Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors
Stewart, D., Richard, M. T., Hugenholtz, H., Dennery, J., Bélanger, R., Gérin-Lajoie, J., Montpetit, V., Nundy, D., Prior, J., & Hopkins, H. S. (1984) · Journal of Neuro-Oncology · doi:10.1007/bf00177899 · Cited by 75
Interaction between cerebrovascular disease and Alzheimer pathology
Saito, S., & Ihara, M. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000239 · Cited by 69
Li, J., Wu, J., Bao, X., Honea, N., Xie, Y., Kim, S., Sparreboom, A., & Sanai, N. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0983 · Cited by 68
Mittapalli, R. K., Adkins, C. E., Bohn, K. A., Mohammad, A. S., Lockman, J. A., & Lockman, P. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1711 · Cited by 68
Fine, R. L., Chen, J., Balmaceda, C., Bruce, J. N., Huang, M., Desai, M., Sisti, M. B., McKhann, G. M., Goodman, R. R., Bertino, J. S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2356 · Cited by 66
Phillips, G. D. L., Nishimura, M. C., Lacap, J. A., Kharbanda, S., Mai, E., Tien, J., Malesky, K., Williams, S. P., Mařı́k, J., & PHILLIPS, H. S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4279-4 · Cited by 66
Liu, D.-Z., Cheng, Y., Cai, R.-Q., Wang, B., Cui, H., Liu, M., Zhang, B.-L., Mei, Q.-B., & Zhou, S.-Y. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.01.004 · Cited by 66
Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome
Karmur, B., Philteos, J. G., Abbasian, A., Zacharia, B., Lipsman, N., Levin, V., Grossman, S., & Mansouri, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.563840 · Cited by 66
Mohammad, A. S., Griffith, J. I. G., Adkins, C. E., Shah, N., Sechrest, E. R., Dolan, E. L., Terrell-Hall, T. B., Hendriks, B. S., Lee, H., & Lockman, P. R. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2278-0 · Cited by 64
Varrone, A., Varnäs, K., Jučaitė, A., Cselényi, Z., Johnström, P., Schou, M., Vázquez‐Romero, A., Moein, M. M., Halldin, C., Brown, A. P., et al. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19843776 · Cited by 64
Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
Gargini, R., Segura‐Collar, B., & Gómez, P. S. (2020) · Cancers · doi:10.3390/cancers12061622 · Cited by 64
Côté, J., Bovenzi, V., Savard, M., Dubuc, C., Fortier, A., Neugebauer, W. A., Tremblay, L., Müller‐Esterl, W., Tsanaclis, A. M. C., Lepage, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037485 · Cited by 56
Lack of Angiogenesis in Experimental Brain Metastases
Bugyik, E., Dezső, K., Reiniger, L., László, V., Tóvári, J., Tímár, J., Nagy, P., Klepetko, W., Döme, B., & Paku, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318233afd7 · Cited by 55
Hashizume, K., & Black, K. L. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.8.725 · Cited by 54
van Hoppe, S., Jamalpoor, A., Rood, J. J. M., Wagenaar, E., Sparidans, R. W., Beijnen, J. H., & Schinkel, A. H. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104297 · Cited by 54
Baisiwala, S., Auffinger, B., Caragher, S. P., Shireman, J. M., Ahsan, R., Lee, G., Hasan, T., Park, C., Saathoff, M. R., Christensen, A. C., et al. (2019) · Stem Cells International · doi:10.1155/2019/6107456 · Cited by 51
Liu, L., Xue, Y., & Liu, Y. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0124-x · Cited by 47
Thorsen, F., Fite, B. Z., Mahakian, L. M., Seo, J. W., Qin, S., Harrison, V. S. R., Johnson, S., Ingham, E. S., Caskey, C. F., Sundstrøm, T., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.019 · Cited by 46
Nounou, M. I., Adkins, C. E., Rubinchik, E., Terrell-Hall, T. B., Afroz, M., Vitalis, T., Gabathuler, R., Tian, M., & Lockman, P. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2015-0 · Cited by 45
Chang, W.-Y., Wu, Y., Su, P., Yang, S., Lin, C., & Su, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192161 · Cited by 43
Gril, B., Wei, D., Zimmer, A. S., Robinson, C. M., Khan, I., Difilippantonio, S., Overstreet, M. G., & Steeg, P. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa118 · Cited by 42
Self-citationHuman central nervous system and plasma pharmacology of mitoxantrone
Green, R. M., Stewart, D. J., Hugenholtz, H., Richard, M. T., Thibault, M., & Montpetit, V. (1988) · Journal of Neuro-Oncology · doi:10.1007/bf00163544 · Cited by 41
Becker, C. M., Oberoi, R. K., McFarren, S. J., Muldoon, D. M., Pafundi, D. H., Pokorny, J. L., Brinkmann, D. H., Ohlfest, J. R., Sarkaria, J. N., Largaespada, D. A., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov081 · Cited by 39
Chaves, C., Declèves, X., Taghi, M., Menet, M., Lacombe, J., Varlet, P., Olaciregui, N. G., Carcaboso, A. M., & Cisternino, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050399 · Cited by 39
Gefitinib concentrations in human glioblastoma tissue
Höfer, S., & Frei, K. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9257-3 · Cited by 38
Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Zimmer, A. S., Steinberg, S. M., Smart, D. D., Gilbert, M. R., Armstrong, T. S., Burton, E., Houston, N. D., Biassou, N. M., Gril, B., Brastianos, P. K., et al. (2020) · Future Oncology · doi:10.2217/fon-2020-0094 · Cited by 37
Self-citationMorad, G., Daisy, C. C., Otu, H. H., Libermann, T. A., Dillon, S. T., & Moses, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113851 · Cited by 37
Author Correction: A molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andræ, J., Ando, K., Gaudio, F. D., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0232-x · Cited by 34
Association of Complement Factor D and H Polymorphisms with Recurrent Pregnancy Loss
Cho, H. Y., Park, H. S., Ko, E. J., Ryu, C. S., Kim, J. O., Kim, Y. R., Ahn, E. H., Lee, W. S., & Kim, N. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010017 · Cited by 34
Samala, R., Thorsheim, H. R., Goda, S., Taskar, K. S., Gril, B., Steeg, P. S., & Smith, Q. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2012-3 · Cited by 33
Self-citationTéglási, V., Csűry, T. D., Dezső, K., Bugyik, E., Szabó, V., Szállási, Z., Paku, S., & Reiniger, L. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz007 · Cited by 32
Su, B., Wang, R., Xie, Z., Ruan, H., Li, J., Xie, C., Lu, W., Wang, J., Wang, D., & Liu, M. (2018) · Small · doi:10.1002/smll.201702331 · Cited by 31
Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments
Lee, S., Seo, Y., Bae, J., Chu, K., Kim, J. W., Choi, S. H., Kim, T. M., Kim, I. H., Park, S., & Park, C. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0695-z · Cited by 26
Bao, X., Wu, J., Jiang, J., Tien, A., Sanai, N., & Li, J. (2021) · Clinical and Translational Science · doi:10.1111/cts.12978 · Cited by 25
Whittle, I. R., Malcolm, G. P., Jodrell, D. I., & Reid, M. (1999) · British Journal of Neurosurgery · doi:10.1080/02688699943871 · Cited by 24
Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis
Shah, N., Liu, Z., Tallman, R. M., Mohammad, A. S., Sprowls, S. A., Saralkar, P. A., Vickers, S. D., Pinti, M. V., Gao, W., & Lockman, P. R. (2020) · BMC Cancer · doi:10.1186/s12885-020-06808-2 · Cited by 23
The cerebral microvasculature: Basic and clinical perspectives on stroke and glioma
Hoque, M. M., Abdelazim, H., Jenkins-Houk, C., Wright, D., Patel, B. M., & Chappell, J. C. (2020) · Microcirculation · doi:10.1111/micc.12671 · Cited by 19
Henry, M. N., Chen, Y., McFadden, C. D., Simedrea, F. C., & Foster, P. J. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000136 · Cited by 14
Zheng, B., Yang, S., Tian, Q., Xie, Y., Zhang, S., & Lee, R. J. (2019) · Anticancer Research · doi:10.21873/anticanres.13285 · Cited by 14
Higuchi, T., Oshiro, H., Zhang, Z., Miyake, K., Sugisawa, N., Katsuya, Y., Yamamoto, N., Hayashi, K., Kimura, H. J., Miwa, S., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.01.007 · Cited by 11
Pernet‐Gallay, K., Jouneau, P., Bertrand, A., Delaroche, J., Farion, R., Rémy, C., & Barbier, E. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654157 · Cited by 10
The Blood-Brain Barrier in Glioblastoma: Pathology and Therapeutic Implications
Kealy, J., & Campbell, M. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46505-0_4 · Cited by 3
Cited by
Targeting HER2-positive breast cancer: advances and future directions
Swain, S. M., Shastry, M., & Hamilton, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00579-0 · Cited by 1,160
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Tiwari, P., Yadav, K., Shukla, R. P., Gautam, S., Marwaha, D., Sharma, M., & Mishra, P. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.016 · Cited by 88
Metadata
- Authors
- Steeg, P. S.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2021-07-12
- Volume
- 18
- Issue
- 11
- Pages
- 696-714
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W3180349164
- Cited by
- 287
- References
- 157
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.